21 Oct ACG 2022 Annual Scientific Meeting, Charlotte, North Carolina

Search
Close this search box.
ASX:RHT

About Resonance Health

Resonance Health is a MedTech company headquartered in Australia, that specialises in the development and commercialisation of non-invasive medical imaging analysis.

Our portfolio includes Core Lab and AI powered products to partner with clinicians and radiologists for diagnosis, and management of patients in a variety of clinical settings. Our products and services are also used by pharma companies in clinical trials.

Core Lab Products

We provide innovative industry leading quantitative calculations and evaluations essential in the management of particular diseases, especially in relation to iron overload and hepatic steatosis.



Our flagship product FerriScan®, launched in 2005, provides a highly precise evaluation of Liver Iron Concentration using R2-MRI technology, essential for the care of Thalassaemia patients and other iron overload related conditions. FDA Cleared, CE Marked, UKCA Marked and ARTG listed.​

 

Cardiac T2* is the most widely accepted MRI-based method for heart iron assessment. FDA Cleared, CE Marked, UKCA Marked and ARTG listed.​



BoneMarrowR2 is an MRI-based method for bone marrow iron assessment. 

AI Products

Since the success of FerriScan®, Resonance Health has amplified its portfolio by developing AI Powered products that use a specially trained convolutional neural network (artificial intelligence – machine learning) to analyse MR and other medical images.



FerriSmart® is an automated AI powered solution for evaluating Liver Iron Concentration. FDA Cleared, UKCA Marked, CE Marked and ARTG listed.​



HepaFatSmart® is an automated AI powered multi-metric evaluation of liver fat. FDA Cleared, UKCA Marked and ARTG listed.​



LiverSmart® is an AI powered solution for liver multi-metric evaluation that combines FerriSmart® and HepaFatSmart® into a single consolidated report. FDA-cleared.

Research Products

Resonance Health continuously invests in research tools that can be used in clinical studies. Depending on your needs we can tailor the acquisition protocol to suit the organ of interest.

LungSmart is an automated AI powered analysis of PE quantum and volume using CTPA images.

OrganFe-Scan is a standardised and reliable MRI-based solution for evaluating organ iron such as, brain, kidney, pancreas and spleen.

OrganFat-Scan is a standardised and reliable MRI-based solution for evaluating organ fat such as pancreas and spleen.

Calibration Products

Resonance Health manufactures high quality phantoms for the calibration of MRI machines. Quality assured under ISO 13485:2016.



T1CMR Phantom: T1MES phantom for T1 and ECV mapping of MRI scanners. FDA Listed, UKCA Marked and CE Marked.



T2CMR Phantom: T2MES phantom for T2 and ECV mapping of MRI scanners.



Other bespoke Phantom products on request.

Clinical Trial Services

Resonance Health has extensive experience in providing quantitative imaging CRO services for multinational and multicenter clinical trials worldwide.

HISTORY OF RESONANCE HEALTH

2000

Professor Tim St Pierre discovers a new way of diagnosing iron levels using MRI.

2005

Resonance Health gets ISO certified (ISO 13485:2016). FerriScan®, Core Lab based MRI evaluation of liver iron concentration (LIC), obtains regulatory clearance: fda svg , ce svg and TGA.

2011

Cardiac-T2*, Core Lab based MRI evaluation of cardiac iron, obtains regulatory clearance:fda svg , ce svg and TGA.

2013

HepaFat-Scan®, Core Lab based MRI evaluation of liver fat obtains regulatory clearance:fda svg , ce svg and TGA.

2017

Global alert issued from the Thalassaemia International Federation (TIF) regarding use of unregulated T2* techniques and recognition of FerriScan® as the only validated method. 

Bone Marrow R2-MRI test obtains regulatory clearance:

fda svg

Beta Testing commences for new cloud -based AI solutions. 

Milestone achieved: 45,000 FerriScan® patients globally to date. 

 Resonance Health enters into strategic partnership with Perth Radiological Clinic for the expansion of all AI. 

2018

FerriSmart®, AI solution for LIC quantification, obtains regulatory clearance:fda svg , ce svg and TGA.

Milestone achieved: over 55,000 FerriScans processed globally to date.

2019

Successfully trained HepaFat®-AI, an AI solution for the automated assessment of liver fat from MRI data. 

2020

HepaFat-AI® obtains regulatory clearance from fda svg.

2021

HepaFat-AI® obtains TGA regulatory clearance. LiverSmart® obtains regulatory clearance from fda svg .

2022

Milestone achieved: over 75,000 FerriScans processed globally to date.